Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Change in Cash (2016 - 2025)

Avanos Medical's Change in Cash history spans 11 years, with the latest figure at $18.7 million for Q4 2024.

  • For Q4 2024, Change in Cash rose 196.39% year-over-year to $18.7 million; the TTM value through Dec 2024 reached $20.0 million, up 150.0%, while the annual FY2025 figure was -$17.9 million, 189.5% down from the prior year.
  • Change in Cash for Q4 2024 was $18.7 million at Avanos Medical, up from -$3.2 million in the prior quarter.
  • Across five years, Change in Cash topped out at $25.3 million in Q3 2023 and bottomed at -$68.5 million in Q4 2020.
  • The 5-year median for Change in Cash is -$2.9 million (2020), against an average of -$4.9 million.
  • The largest annual shift saw Change in Cash skyrocketed 1200.0% in 2022 before it tumbled 731.82% in 2023.
  • A 5-year view of Change in Cash shows it stood at -$68.5 million in 2020, then skyrocketed by 130.22% to $20.7 million in 2021, then plummeted by 48.31% to $10.7 million in 2022, then plummeted by 281.31% to -$19.4 million in 2023, then surged by 196.39% to $18.7 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Change in Cash are $18.7 million (Q4 2024), -$3.2 million (Q3 2024), and $16.4 million (Q2 2024).